Limited Efficacy of High-Dose Methotrexate to Prevent CNS Relapse in Intravascular Large B-Cell Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Limited efficacy of high-dose methotrexate to prevent the central nervous system relapse in patients with IVLBCL
Leukemia and Lymphoma 2022 Sep 16;[EPub Ahead of Print], T Terao, T Tsushima, D Ikeda, A Fukumoto, Y Kamura, A Kuzume, R Tabata, D Miura, K Narita, M Takeuchi, K MatsueFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.